Bio:

Julia Simensen studied Molecular Biosciences at the University of Oslo, Norway, from 2014-2020. She performed her Master’s thesis under the supervision of Dr. Viola Lobert (Rusten’s group), where she became interested in colorectal cancer research with focus on studying the disease in 3D cultures (i.e. organoids and spheroids). After MSc graduation in June 2020, she worked as a summer internship student supervised by Dr. Marie Rogne (Eskeland’s group) through the University of Oslo: Life Science program. Here she gained experience in liposarcoma research and molecular techniques used to study cytogenetics, such as fluorescence in situ hybridization (FISH). In September 2020, she was hired by Hovig’s group to participate as an engineer in projects related to Covid-19 (September-December 2020) and prostate cancer (from September 2020-2021) – see listing below. Since April 2021, Simensen worked as a Special Engineer in the “Autophagy in cancer” project group led by Dr. Nikolai Engedal and in the Urbanucci Lab project group led by Dr. Alfonso Urbanucci

Covid-19 project (September 2020-December 2020)

Lead by Dr. Per O. Ekstrøm

Radiosensitizers in prostate cancer project (September 2020-2021)

Urbanucci Lab, led by Dr. Alfonso Urbanucci

Autophagy in prostate cancer project (April 2021-2022)

Engedal Lab, led by Dr. Nikolai Engedal